Pyridine → tert-butyl (2S)-2-(5-[4-(hydroxymethyl)phenoxymethyl]-1,2,4-oxadiazol-3-yl)-1-piperidinecarboxylate
反応式
N[C@@:2]1(/[CH:15]=[N:16]\[O:17][C:18](=O)[CH2:19][O:20][C:21]2[CH:26]=[CH:25][C:24]([CH2:27][OH:28])=[CH:23][CH:22]=2)[CH2:7][CH2:6][CH2:5][CH2:4][N:3]1[C:8]([O:10][C:11]([CH3:14])([CH3:13])[CH3:12])=[O:9].[N:30]1C=CC=CC=1>>[OH:28][CH2:27][C:24]1[CH:25]=[CH:26][C:21]([O:20][CH2:19][C:18]2[O:17][N:16]=[C:15]([C@@H:2]3[CH2:7][CH2:6][CH2:5][CH2:4][N:3]3[C:8]([O:10][C:11]([CH3:14])([CH3:13])[CH3:12])=[O:9])[N:30]=2)=[CH:22][CH:23]=1参加物
実験手順
tert-Butyl (Z)-(2S)-2-amino[(2-[4-(hydroxymethyl)phenoxy]acetyloxy)imino]methyl-1-piperidinecarboxylate (see Preparation 12] (2.94 g) was dissolved in pyridine (30 ml) and heated under reflux for 18 hours. The reaction mixture was cooled and the solvent removed under reduced pressure. The residue was partitioned between ethyl acetate and water, the organic layer was separated, dried over magnesium sulphate and the solvent removed under reduced pressure. The crude product was purified by column chromatography on silica gel eluting with a solvent gradient of 50:50 changing to 0:100 (in 10% increments), by volume, hexane:ethyl acetate to afford tert-butyl (2S)-2-(5-[4-(hydroxymethyl)phenoxymethyl]-1,2,4-oxadiazol-3-yl)-1-piperidinecarboxylate (1.06 g).
後処理
- customPreparation 12] (2.94 g)
- temperatureheated
- temperatureunder reflux for 18 hours
- temperatureThe reaction mixture was cooled
- customthe solvent removed under reduced pressure
- customThe residue was partitioned between ethyl acetate and water
- customthe organic layer was separated
- dry with materialdried over magnesium sulphate
- customthe solvent removed under reduced pressure
- customThe crude product was purified by column chromatography on silica gel eluting with a solvent gradient of 50:50 changing to 0:100 (in 10% increments), by volume, hexane
出典と根拠
- ORDレコード
- ord-263dc112a84d4161b37ca21b86569cfc
- 出典データセット
- uspto-grants-2003_08
- 特許番号
- US06610707B1
反応ノート
読み込み中…